(Q35941557)

English

Rationally engineered nanoparticles target multiple myeloma cells, overcome cell-adhesion-mediated drug resistance, and show enhanced efficacy in vivo

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

11 August 2017

Rationally engineered nanoparticles target multiple myeloma cells, overcome cell-adhesion-mediated drug resistance, and show enhanced efficacy in vivo (English)

1 reference

Europe PubMed Central

11 August 2017

multiple drug resistance

1 reference

based on heuristic

inferred from title

multiple myeloma

1 reference

based on heuristic

inferred from title

0 references

1 reference

based on heuristic

inferred from title

Tanyel Kiziltepe

1

object named as

T Kiziltepe

1 reference

Europe PubMed Central

11 August 2017

9

object named as

B Bilgicer

1 reference

Europe PubMed Central

11 August 2017

author name string

J D Ashley

2

1 reference

Europe PubMed Central

11 August 2017

J F Stefanick

3

1 reference

Europe PubMed Central

11 August 2017

Y M Qi

4

1 reference

Europe PubMed Central

11 August 2017

N J Alves

5

1 reference

Europe PubMed Central

11 August 2017

M W Handlogten

6

1 reference

Europe PubMed Central

11 August 2017

M A Suckow

7

1 reference

Europe PubMed Central

11 August 2017

R M Navari

8

1 reference

Europe PubMed Central

11 August 2017

publication date

20 April 2012

1 reference

Europe PubMed Central

11 August 2017

Blood Cancer Journal

1 reference

Europe PubMed Central

11 August 2017

2

1 reference

Europe PubMed Central

11 August 2017

4

1 reference

Europe PubMed Central

11 August 2017

e64

1 reference

Europe PubMed Central

11 August 2017

https://scigraph.springernature.com/pub.10.1038/bcj.2012.10

0 references

Targeting the interplay between myeloma cells and the bone marrow microenvironment in myeloma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3346680

2 October 2017

The selective adhesion molecule inhibitor Natalizumab decreases multiple myeloma cell growth in the bone marrow microenvironment: therapeutic implications

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3346680

2 October 2017

Overcoming in vivo barriers to targeted nanodelivery

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3346680

2 October 2017

Future directions of next-generation novel therapies, combination approaches, and the development of personalized medicine in myeloma.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3346680

2 October 2017

Multifunctionality of lipid-core micelles for drug delivery and tumour targeting

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3346680

2 October 2017

Mixed pH-sensitive polymeric micelles for combination drug delivery

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3346680

2 October 2017

Advances in polymeric micelles for drug delivery and tumor targeting

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3346680

2 October 2017

Fullerenol-cytotoxic conjugates for cancer chemotherapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3346680

2 October 2017

Selectively targeting T- and B-cell lymphomas: a benzothiazole antagonist of alpha4beta1 integrin

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3346680

2 October 2017

Polymeric drugs for efficient tumor-targeted drug delivery based on EPR-effect

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3346680

2 October 2017

Multifunctional micellar nanomedicine for cancer therapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3346680

2 October 2017

Bortezomib overcomes cell-adhesion-mediated drug resistance through downregulation of VLA-4 expression in multiple myeloma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3346680

2 October 2017

Drug delivery with carbon nanotubes for in vivo cancer treatment

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3346680

2 October 2017

ANTI-ADHESION evolves to a promising therapeutic concept in oncology

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3346680

2 October 2017

Liposomal doxorubicin in combination with bortezomib for relapsed or refractory multiple myeloma.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3346680

2 October 2017

Mouse models of human myeloma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3346680

2 October 2017

Pegylated liposomal doxorubicin and immunomodulatory drug combinations in multiple myeloma: rationale and clinical experience.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3346680

2 October 2017

JS-K, a GST-activated nitric oxide generator, induces DNA double-strand breaks, activates DNA damage response pathways, and induces apoptosis in vitro and in vivo in human multiple myeloma cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3346680

2 October 2017

Bifunctional ligands that target cells displaying the alpha v beta3 integrin

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3346680

2 October 2017

Micellar nanocarriers: pharmaceutical perspectives

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3346680

2 October 2017

Ligand-targeted liposomes for cancer treatment

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3346680

2 October 2017

Determination of doxorubicin levels in whole tumor and tumor nuclei in murine breast cancer tumors

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3346680

2 October 2017

Role of liposomal anthracyclines in the treatment of multiple myeloma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3346680

2 October 2017

Anti-alpha4 integrin monoclonal antibody inhibits multiple myeloma growth in a murine model.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3346680

2 October 2017

Rational design of potent and selective VLA-4 inhibitors and their utility in the treatment of asthma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3346680

2 October 2017

Novel therapeutic approaches for multiple myeloma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3346680

2 October 2017

Therapeutic cancer targeting peptides

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3346680

2 October 2017

ATM phosphorylates histone H2AX in response to DNA double-strand breaks

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3346680

2 October 2017

VLA-4-dependent myeloma cell adhesion

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3346680

2 October 2017

Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3346680

2 October 2017

Cell adhesion mediated drug resistance (CAM-DR): role of integrins and resistance to apoptosis in human myeloma cell lines

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3346680

2 October 2017

Doxorubicin hydrochloride-associated renal failure

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3346680

2 October 2017

Anthracyclines in haematology: preclinical studies, toxicity and delivery systems

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3346680

27 July 2018

In vitro characterization of PEGylated phospholipid micelles for improved drug solubilization: effects of PEG chain length and PC incorporation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3346680

24 September 2018

Bone marrow angiogenic ability and expression of angiogenic cytokines in myeloma: evidence favoring loss of marrow angiogenesis inhibitory activity with disease progression.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3346680

24 September 2018

Amelioration of doxorubicin-induced cardiac and renal toxicity by pirfenidone in rats

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3346680

24 September 2018

Interaction between leukemic-cell VLA-4 and stromal fibronectin is a decisive factor for minimal residual disease of acute myelogenous leukemia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3346680

24 September 2018

Very late antigen 4 (VLA4) antagonists as anti-inflammatory agents

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3346680

24 September 2018

Potent alpha 4 beta 1 peptide antagonists as potential anti-inflammatory agents

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3346680

24 September 2018

Polyethylene glycol-diacyllipid micelles demonstrate increased acculumation in subcutaneous tumors in mice

1 reference

https://pubmed.ncbi.nlm.nih.gov/22829966

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prognostic value of bone marrow angiogenesis in multiple myeloma: use of light microscopy as well as computerized image analyzer in the assessment of microvessel density and total vascular area in multiple myeloma and its correlation with various cl

1 reference

https://pubmed.ncbi.nlm.nih.gov/22829966

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Anthracycline-induced cardiotoxicity

1 reference

https://pubmed.ncbi.nlm.nih.gov/22829966

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Establishing a new rat model of central venous sinus thrombosis and analyzing its pathophysiological and apoptotic changes

1 reference

https://pubmed.ncbi.nlm.nih.gov/22829966

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Polyvalent Interactions in Biological Systems: Implications for Design and Use of Multivalent Ligands and Inhibitors

1 reference

https://pubmed.ncbi.nlm.nih.gov/22829966

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Integrin function in chronic lymphocytic leukemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/22829966

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Spherical Micelles and Other Self-Assembled Structures in Dilute Aqueous Mixtures of Poly(Ethylene Glycol) Lipids

1 reference

https://api.crossref.org/works/10.1038%2FBCJ.2012.10

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1038/BCJ.2012.10

1 reference

Europe PubMed Central

11 August 2017

Dimensions Publication ID

0 references

1 reference

Europe PubMed Central

11 August 2017

1 reference

Europe PubMed Central

11 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q35941557&oldid=2033128712"